Conexeu Sciences Inc.

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for medical aesthetics and tissue repair. The company offers patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform. This platform is used in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring, specifically for face, breast, and butt volume restoration. Conexeu Sciences Inc. also has CXU collagen gel, an investigational product. This gel targets therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data. These products are positioned as alternatives to conventional fillers or implants. Currently, the products are investigational and are pending regulatory clearance for certain applications. Conexeu Sciences Inc. serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors. This includes clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.